Markets › United States › NYSE › DGX

Quest Diagnostics Inc

NYSE:DGXHealthcareCBOE:SPESGNASDAQ:NQUSMG

$234.90−0.04%At closeAt close · Mon 19 Oct · ≈ AED 862.67 · Market cap $25.93B · Next earnings Tue 20 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	38.5%	39.0%	34.7%	33.2%	32.9%	31.9%	—	—
Operating margin	20.9%	22.1%	14.4%	13.6%	13.6%	14.5%	14.5%	+0.0 pts
Net margin	15.2%	18.5%	9.6%	9.2%	8.8%	9.0%	9.5%	+0.5 pts
EBITDA margin	25.5%	29.3%	18.4%	18.7%	19.2%	19.9%	—	—
Return on equity	21.2%	31.0%	16.1%	13.5%	12.9%	13.8%	14.4%	+0.5 pts
Return on assets	10.2%	14.7%	7.4%	6.1%	5.4%	6.1%	6.4%	+0.3 pts
Return on capital employed	16.1%	20.1%	12.7%	10.3%	9.6%	11.5%	—	—
Debt / equity	0.7×	0.7×	0.8×	0.9×	1.0×	1.0×	0.9×	−1.6%
Debt / assets	34.3%	35.1%	36.7%	39.2%	43.9%	42.6%	—	—
Interest coverage	11.9×	15.7×	9.6×	7.7×	6.0×	5.8×	—	—
Current ratio	1.7×	1.6×	1.2×	1.3×	1.1×	1.0×	1.0×	+0.0%
Quick ratio	1.6×	1.4×	1.1×	1.2×	1.0×	1.0×	—	—
Cash ratio	0.7×	0.5×	0.2×	0.4×	0.3×	0.2×	0.2×	+0.0%
Asset turnover	0.7×	0.8×	0.8×	0.7×	0.6×	0.7×	—	—
Inventory turnover	26.0×	31.6×	33.6×	32.6×	35.3×	39.7×	—	—
Receivables turnover	6.2×	7.5×	8.3×	7.6×	7.6×	7.8×	—	—
Dividend payout	20.8%	15.5%	32.2%	36.8%	38.0%	35.6%	—	—